| |
Company
Roster
|
|
Total
Insiders : |
49 |
|
|
|
Total
Direct Shares :
|
5,206,216 |
|
|
Total
Indirect Shares :
|
2,645,542 |
| |
%
Held by Insiders:
|
13.75% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Stanton Marshall S. |
SVP, Clinical & MD Affair |
2024-03-20 |
83,296 |
2021-03-16 |
0 |
| Green Andrew M |
VP Regulatory |
2024-03-15 |
41,121 |
2022-02-17 |
0 |
| Getz Matthew A |
VP, Human Resources |
2024-03-12 |
43,536 |
2020-02-19 |
0 |
| Holloway Jean F |
SVP, General Counsel |
2024-03-05 |
169,711 |
2015-04-01 |
0 |
| Maney Rochelle L. |
VP, Quality |
2024-03-05 |
46,569 |
|
0 |
| Mackin James P |
President & CEO |
2024-03-05 |
706,038 |
2014-09-02 |
0 |
| Davis John E |
Chief Commercial Officer |
2024-03-05 |
165,690 |
2015-09-10 |
0 |
| Horton Amy |
VP, Chief Accounting Officer |
2024-03-05 |
139,989 |
|
0 |
| Tyrs Florian |
VP, Global Operations |
2024-02-27 |
21,558 |
2024-02-27 |
4,131 |
| Berry Lance A |
Executive VP, CFO |
2024-02-23 |
79,064 |
2023-12-06 |
0 |
| Thomson Robert C |
VP Research & Development |
2024-02-23 |
13,291 |
2023-06-09 |
0 |
| Borgstrom Marna P |
Director |
2023-06-06 |
36,474 |
2018-08-09 |
0 |
| Salveson Jon W |
Director |
2023-06-06 |
117,226 |
2012-06-07 |
0 |
| Hoff Elizabeth A |
Director |
2023-06-06 |
18,775 |
2022-11-08 |
0 |
| Burbank Jeffrey H |
Director |
2023-06-06 |
41,182 |
2018-05-23 |
0 |
| Ackerman Thomas F |
Director |
2023-06-06 |
137,282 |
2007-05-09 |
0 |
| Bullock James W |
Director |
2023-06-06 |
56,033 |
|
0 |
| Bevevino Daniel J |
Director |
2023-06-06 |
137,447 |
2007-05-09 |
0 |
| Maier Dennis B |
SVP, Operations |
2023-06-06 |
34,724 |
2019-03-05 |
0 |
| Semedo Anthony B. |
Director |
2023-06-06 |
37,579 |
2021-11-29 |
0 |
| Lee David Ashley |
Executive VP, COO & CFO |
2023-03-02 |
347,217 |
2023-03-02 |
22,560 |
| Barthold Franz Peter |
VP, Research & Development |
2022-11-08 |
32,516 |
|
0 |
| Morgan Harvey |
Director |
2021-08-30 |
50,768 |
2021-08-30 |
46,342 |
| Ronald D Mccall |
Director |
2021-08-25 |
121,768 |
2018-08-09 |
16,000 |
| Capps Scott B |
VP, Clinical Research |
2021-03-12 |
153,203 |
|
0 |
| Simpson Michael S |
SVP, Regulatory Affairs and QA |
2021-03-05 |
33,698 |
2019-03-05 |
0 |
| Bogenschuetz Thomas J |
VP, EMEA & General Manager |
2020-03-12 |
23,451 |
2019-03-05 |
0 |
| Saurini Sherry M |
VP, Quality |
2019-03-14 |
25,084 |
2016-02-19 |
0 |
| Mcdermid James M |
SVP, CHRO |
2019-03-14 |
30,806 |
|
0 |
| Ronald C Elkins |
Director |
2018-09-05 |
64,843 |
2007-05-04 |
0 |
| Matthews William Robert |
Senior VP, Operations, Quality |
2018-03-05 |
39,883 |
2015-09-10 |
0 |
| Gale David C |
VP, Research & Development |
2017-11-16 |
77,135 |
|
0 |
| Benson James |
Director |
2017-10-02 |
54,086 |
2007-05-09 |
0 |
| Anderson Steven G |
Former Executive Chairman |
2015-04-09 |
1,271,846 |
2015-04-09 |
107,924 |
| Fronk David |
VP, Regulatory Affairs |
2015-03-07 |
110,559 |
2004-11-02 |
0 |
| Anderson Bruce G. |
VP, US Sales &Global Marketing |
2015-03-07 |
42,106 |
2015-03-07 |
61,990 |
| Lang David P. |
VP, Intl Sales & Marketing |
2015-02-26 |
73,441 |
|
0 |
| Burris Jeffrey W |
Vice President & Gen. Counsel |
2014-08-15 |
95,221 |
2010-02-16 |
0 |
| Seery Gerald B |
Sr. VP, Sales and Marketing |
2012-11-30 |
71,999 |
|
0 |
| Heacox Albert E |
Sr. VP Research and Devl |
2011-08-15 |
112,577 |
2011-08-15 |
5,346 |
| Cook John M |
Director |
2009-06-09 |
85,000 |
2009-06-09 |
19,500 |
| Theodore Philip A |
Officer |
2007-09-04 |
8,100 |
2007-09-04 |
0 |
| Lacy Virginia C |
Director |
2007-04-24 |
2,500 |
2007-04-24 |
443,659 |
| Van Dyne Bruce J Md |
Director |
2006-08-01 |
12,800 |
2006-08-01 |
0 |
| Ashmore Sidney B |
Vice President of Marketing |
2006-01-18 |
42,728 |
2004-11-02 |
0 |
| Lynch Thomas J |
VP - Reg. Aff./Quality Assur. |
2004-11-02 |
5,000 |
2004-11-02 |
0 |
| Black Kirby S |
Sr. Vice President, R&D |
2004-09-21 |
55,131 |
2004-09-21 |
90 |
| Wyk Vander James C |
VP - Product Integrity |
2004-09-14 |
36,165 |
2004-09-14 |
0 |
| Oss Capital Management |
10% Owner |
|
0 |
2007-05-31 |
1,918,000 |
|
0.65 (3.11%) 
